查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1552910

數位神經生物標記物市場規模、佔有率、趨勢分析報告：按類型、臨床實踐、最終用途、地區、細分趨勢：2024-2030

Digital Neuro Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearable, Mobile Based Applications), By Clinical Practice, By End Use, By Region And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

數位神經生物標記市場成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，預計到 2030 年，全球數位神經生物標記市場規模將達到 28.2 億美元，預計 2024 年至 2030 年複合年成長率為 25.3%。

該市場受到多種因素的推動，包括神經系統疾病的日益流行、全球老年人口的不斷成長、技術進步、個性化醫療的需求以及私營和上市公司對市場投資的增加，從而實現了顯著的成長。此外，數位醫療技術的監管核准和報銷範圍的擴大正在推動數位神經生物標記的採用。監管機構已經認知到這些技術在改善患者治療效果方面的潛力，從而製定了支持性政策和報銷模式。

阿茲海默症、帕金森氏症和多發性硬化症等神經系統疾病的盛行率不斷增加，大大推動了對數位神經生物標記的需求。這些複雜的疾病需要準確、持續的監測和早期發現，以有效管理症狀並改善患者的治療結果。數位神經生物標記物透過穿戴式感測器和行動醫療應用等先進技術準確追蹤神經功能和疾病進展。透過提供即時資料和見解，這些生物標記能夠實現早期療育和個人化治療策略，滿足及時、有針對性地管理神經系統疾病的迫切需求。例如，美國有近 100 萬人患有多發性硬化症 (MS)。根據美國國家多發性硬化症協會估計，全球整體有超過 280 萬人患有多發性硬化症。大多數被診斷出患有多發性硬化症的人年齡在 20 至 50 歲之間，但它可以發生在任何年齡。此外，女性多發性硬化症的診斷率高於男性。

神經系統疾病的早期發現和預防變得越來越重要。數位神經生物標記物具有比傳統方法更早檢測疾病標記物的優勢，從而可以及時干預和管理。人工智慧和機器學習的整合也在推動市場成長；例如，2022 年 9 月，Nutromics 從 Dexcom Ventures 獲得了 1400 萬美元的資金，以推進其「lab-in-a-patch」平台。這項創新技術利用 DNA 感測器來監測各種目標，包括疾病生物標記和治療藥物。此外，將數位神經生物標記物與更廣泛的數位健康平台（例如電子健康記錄（EHR）和遠端醫療）相結合，將提高其效用和可近性。這種整合有助於持續監測和即時資料分析，以改善患者護理和結果。例如，2021 年 10 月，致力於開發先進神經疾病診斷的人工智慧公司 Altoida 開始了為期五年的多中心觀察研究。這項廣泛的研究將包括數千名處於阿茲海默症各個階段的患者，旨在提高我們對疾病連續體的理解並提高診斷能力。

主要企業採用各種策略來維持競爭優勢，包括合併、收購和產品發布。主要市場參與企業的主要策略舉措包括：

  • 2024 年 4 月，Tris Pharma Inc. 與 Brainaze Ltd. 簽訂授權合約，成立 Tris Digital Health。新部門將專注於開發和行銷用於注意力不足過動症（ADHD）和其他神經系統疾病的數位診斷和治療產品。
  • 2024 年 3 月，Cumulus Neuroscience 獲得創新英國 SBRI（小型企業研究計畫）約 125 萬美元的津貼。這筆資金將支持人工智慧診斷工具的開發和檢驗，旨在提高血液生物標記物的準確性。新的人工智慧演算法將血液生物標記與透過 Cumulus 神經評估平台獲得的數位生物標記和人口統計資訊相結合。
  • 2024年1月，哈佛大學約翰·A·保爾森工程與應用科學學院、波士頓大學薩金特健康與復健科學學院和哈佛大學維斯研究所的研發科學家開發了一款柔軟、穿戴式的機器人，旨在幫助帕金森氏症患者走路更順暢。這款創新的機器人服裝會附著在您的大腿和臀部上，並在您每次擺動雙腿時輕輕按壓您的臀部。這種支撐使患者能夠邁出更大的步伐並變得不那麼僵硬，從而提高他們的運動技能和整體行走能力。

數位神經生物標記物市場報告亮點

  • 按類型分類，穿戴式裝置領域以 2023 年最高收益佔有率41.1% 領先市場。基於行動的應用程式領域預計在預測期內將出現最快的複合年成長率。
  • 根據臨床實踐，診斷細分市場在 2023 年以 32.23% 的最高收益佔有率引領市場。預計監測產業在預測期內將出現最快的複合年成長率。
  • 根據最終用途，醫療保健公司細分市場在 2023 年以 50.7% 的最高收益佔有率引領市場。預計醫療保健提供者產業在預測期內將出現最快的複合年成長率。
  • 北美地區在 2023 年以 58.45% 的收益佔有率佔據市場主導地位。對神經系統疾病診斷的需求不斷增加，導致對神經系統生物標記的需求顯著增加。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章數位神經生物標記物市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 數位神經生物標記市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 技術時間表和產品平臺分析
    • 案例研究分析/最終使用案例分析

第4章數位神經生物標記市場：按類型估計和趨勢分析

  • 細分儀表板
  • 數位神經生物標記市場：類型變異分析
  • 數位神經生物標記市場：按類型分類的展望
  • 穿戴式的
  • 基於行動的應用程式
  • 感應器
  • 其他

第5章數位神經生物標記市場：臨床實踐的估計和趨勢分析

  • 細分儀表板
  • 數位神經生物標記市場：臨床實踐變異分析
  • 臨床實務展望：數位神經生物標記市場
  • 診斷數位神經生物標記
  • 數位神經生物標記監測
  • 預測和預後數字神經生物標記
  • 其他

第6章 數位神經生物標記市場：最終用途的估計和趨勢分析

  • 細分儀表板
  • 數位神經生物標記市場：最終用途的變異分析
  • 最終用途展望：數位神經生物標記市場
  • 醫療保健公司
  • 醫療服務提供方
  • 付款人
  • 其他

第7章數字神經生物標記市場：區域估計與趨勢分析

  • 區域儀表板
  • 按地區分類的數位神經生物標記市場波動分析
  • 數位神經生物標記市場：按類型、臨床實踐和最終用途分類的區域估計和趨勢分析
  • 2018-2030年市場規模、預測及趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
    • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 挪威
    • 瑞典
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 市場參與企業分類
  • 主要企業簡介
    • Altoida Inc.
    • Koneksa
    • Biogen Inc.
    • Roche（Navify）
    • NeuraMetrix
    • Merck KGaA
    • Linus Health
    • Neurotrack Technologies, Inc.
    • Huma
    • NeuraLight
Product Code: GVR-4-68040-409-5

Digital Neuro Biomarkers Market Growth & Trends:

The global digital neuro biomarkers market size is anticipated to reach USD 2.82 billion by 2030 and is projected to grow at a CAGR 25.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is witnessing significant growth owing to various factors such as increased prevalence of neurological disorders, rising geriatric population globally, advances in technology, demand for personalized medicine, and increased investment in the market by private and public players. Furthermore, positive regulatory approvals and increasing reimbursement coverage for digital health technologies encourage the adoption of digital neuro biomarkers. Regulatory bodies are recognizing the potential of these technologies to improve patient outcomes, leading to supportive policies and reimbursement models.

The increasing prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis is significantly fueling the demand for digital neuro biomarkers. These complex conditions necessitate accurate, continuous monitoring and early detection to manage symptoms effectively and improve patient outcomes. Digital neuro biomarkers, through advanced technologies such as wearable sensors and mobile health applications, offer precise tracking of neurological functions and disease progression. By providing real-time data and insights, these biomarkers enable early intervention and personalized treatment strategies, addressing the critical need for timely and targeted management of neurological conditions. For instance, in the U.S., close to 1 million individuals are impacted by multiple sclerosis (MS). Globally, it is estimated that over 2.8 million people are living with MS, according to the National Multiple Sclerosis Society. While most MS diagnoses occur between the ages of 20 and 50, the condition can affect individuals at any age. In addition, MS is more commonly diagnosed in women compared to men.

There is a growing emphasis on early detection and prevention of neurological diseases. Digital neuro biomarkers offer the advantage of detecting disease markers at an earlier stage than traditional methods, allowing for timely intervention and management. Integration of AI and machine learning is also driving the market growth, for instance, in September 2022, Nutromics secured USD 14 million in funding from Dexcom Ventures to advance its 'lab-in-a-patch' platform. This innovative technology utilizes DNA sensors to monitor a range of targets, including disease biomarkers and challenging-to-dose medications. Moreover, the integration of digital neuro biomarkers with broader digital health platforms, including electronic health records (EHRs) and telemedicine, enhances their utility and accessibility. This integration facilitates continuous monitoring and real-time data analysis, improving patient care and outcomes. For instance, In October 2021, Altoida, Inc., an AI company at developing advanced neurological disease diagnostics, launched a five-year multicenter observational study. This extensive study will involve thousands of patients across all stages of Alzheimer's disease, aiming to enhance the understanding and diagnostic capabilities of the disease continuum.

Key players are adopting various strategies to maintain a competitive edge such as mergers, acquisition, product launches, etc. Some of the key strategic initiatives by the major market players include:

  • In April 2024, Tris Pharma Inc. entered into a licensing agreement with Braingaze Ltd. and established Tris Digital Health. This new division will focus on the development and distribution of digital diagnostic and therapeutic products for attention-deficit/hyperactivity disorder (ADHD) and other neurological health conditions
  • In March 2024, Cumulus Neuroscience was awarded a grant of nearly USD 1.25 million from the Innovate UK SBRI (Small Business Research Initiative). This funding will support the development and validation of an AI diagnostic tool designed to enhance the accuracy of blood biomarkers. The new AI algorithms will integrate blood biomarkers with digital biomarkers-obtained through the Cumulus Neuroassessment Platform-and demographic information
  • In January 2024, Researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences, Boston University Sargent College of Health & Rehabilitation Sciences, and the Wyss Institute at Harvard University developed a soft, wearable robot designed to assist individuals with Parkinson's disease in walking more smoothly. This innovative robotic garment, which is worn around the thighs and hips, provides a gentle push to the hips during each leg swing. This support helps the patient achieve a longer stride and reduces instances of freezing, improving mobility and overall walking ability

Digital Neuro Biomarkers Market Report Highlights:

  • Based on type, the wearable segment led the market with the largest revenue share of 41.1% in 2023. The mobile-based application segment is expected to witness at the fastest CAGR over the forecast period.
  • Based on clinical practice, the diagnostic segment led the market with the largest revenue share of 32.23% in 2023. The monitoring segment is expected to witness at the fastest CAGR over the forecast period
  • Based on end use, the healthcare companies segment led the market with the largest revenue share of 50.7% in 2023. The healthcare providers segment is expected to witness at the fastest CAGR over the forecast period
  • North America dominated the market with a revenue share of 58.45% in 2023. The rising need for diagnosing neurological disorders has significantly increased the demand for neurological biomarkers

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Clinical Practice
    • 1.2.3. End Use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Clinical practice outlook
    • 2.2.3. End Use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Digital Neuro Biomarkers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Digital Neuro Biomarkers Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
    • 3.3.3. Technology Timeline & Product Pipeline Analysis
    • 3.3.4. Case Study Analysis/ End Use Case Analysis

Chapter 4. Digital Neuro Biomarkers Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Digital Neuro Biomarkers Market: Type Movement Analysis
  • 4.3. Digital Neuro Biomarkers Market by Type Outlook (USD Million)
  • 4.4. Wearables
    • 4.4.1. Wearables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Mobile based Applications
    • 4.5.1. Mobile based Applications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Sensors
    • 4.6.1. Sensors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Digital Neuro Biomarkers Market: Clinical Practice Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Digital Neuro Biomarkers Market: Clinical Practice Movement Analysis
  • 5.3. Digital Neuro Biomarkers Market by Clinical Practice Outlook (USD Million)
  • 5.4. Diagnostic Digital Neuro Biomarkers
    • 5.4.1. Diagnostic Digital Neuro Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Monitoring Digital Neuro Biomarkers
    • 5.5.1. Monitoring Digital Neuro Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Predictive and Prognostic Digital Neuro Biomarkers
    • 5.6.1. Predictive and Prognostic Digital Neuro Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Digital Neuro Biomarkers Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Digital Neuro Biomarkers Market: End Use Movement Analysis
  • 6.3. Digital Neuro Biomarkers Market by End Use Outlook (USD Million)
  • 6.4. Healthcare companies
    • 6.4.1. Healthcare companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Healthcare Providers
    • 6.5.1. Healthcare Providers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Payers
    • 6.6.1. Payers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Digital Neuro Biomarkers Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Digital Neuro Biomarkers Market movement analysis
  • 7.3. Digital Neuro Biomarkers Market: Regional Estimates & Trend Analysis by Type, Clinical Practice & End-use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. North America
    • 7.5.1. North America Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. U.S. Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Canada Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Mexico Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Europe
    • 7.5.6. Europe Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. UK
      • 7.5.7.1. UK Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Germany
      • 7.5.8.1. Germany Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. France
      • 7.5.9.1. France Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.10. Italy
      • 7.5.10.1. Italy Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.11. Spain
      • 7.5.11.1. Spain Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.12. Denmark
      • 7.5.12.1. Denmark Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.13. Norway
      • 7.5.13.1. Norway Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.14. Sweden
      • 7.5.14.1. Sweden Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Japan Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. China Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. India Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. South Korea Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Australia Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Thailand Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Brazil Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Argentina Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. South Africa Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Saudi Arabia Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. UAE Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Kuwait Digital Neuro Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Altoida Inc.
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Koneksa
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Biogen Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Roche (Navify)
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. NeuraMetrix
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Merck KGaA
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Linus Health
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Neurotrack Technologies, Inc.
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Huma
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. NeuraLight
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 4. Global digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 5. Global digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 6. North America digital neuro biomarkers market, by country, 2018 - 2030, (USD Million)
  • Table 7. North America digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 8. North America digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 9. North America digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 10. U.S. digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 11. U.S. digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 12. U.S. digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 13. Canada digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 14. Canada digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 15. Canada digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 16. Mexico digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 17. Mexico digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 18. Mexico digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 19. Europe digital neuro biomarkers market, by country, 2018 - 2030, (USD Million)
  • Table 20. Europe digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 21. Europe digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 22. Europe digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 23. UK digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 24. UK digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 25. UK digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 26. Germany digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 27. Germany digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 28. Germany digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 29. France digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 30. France digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 31. France digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 32. Italy digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 33. Italy digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 34. Italy digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 35. Spain digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 36. Spain digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 37. Spain digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 38. Denmark digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 39. Denmark digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 40. Denmark digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 41. Norway digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 42. Norway digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 43. Norway digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 44. Sweden digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 45. Sweden digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 46. Sweden digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 47. Asia Pacific digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 48. Asia Pacific digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 49. Asia Pacific digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 50. China digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 51. China digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 52. China digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 53. Japan digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 54. Japan digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 55. Japan digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 56. India digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 57. India digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 58. India digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 59. Australia digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 60. Australia digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 61. Australia digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 62. South Korea digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 63. South Korea digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 64. South Korea digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 65. Thailand digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 66. Thailand digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 67. Thailand digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 68. Latin America digital neuro biomarkers market, by country, 2018 - 2030, (USD Million)
  • Table 69. Latin America digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 70. Latin America digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 71. Latin America digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 72. Brazil digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 73. Brazil digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 74. Brazil digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 75. Argentina digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 76. Argentina digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 77. Argentina digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 78. MEA digital neuro biomarkers market, by country, 2018 - 2030, (USD Million)
  • Table 79. MEA digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 80. MEA digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 81. MEA digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 82. South Africa digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 83. South Africa digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 84. South Africa digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 85. Saudi Arabia digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 86. Saudi Arabia digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 87. Saudi Arabia digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 88. UAE digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 89. UAE digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 90. UAE digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)
  • Table 91. Kuwait digital neuro biomarkers market, by type, 2018 - 2030, (USD Million)
  • Table 92. Kuwait digital neuro biomarkers market, by clinical practice, 2018 - 2030, (USD Million)
  • Table 93. Kuwait digital neuro biomarkers market, by end use, 2018 - 2030, (USD Million)

List of Figures

  • Fig. 1. Information procurement
  • Fig. 2. Primary research pattern
  • Fig. 3. Market research approaches
  • Fig. 4. Value chain-based sizing & forecasting
  • Fig. 5. Market formulation & validation
  • Fig. 6. Digital neuro biomarkers market segmentation
  • Fig. 7. Market driver analysis (current & future impact)
  • Fig. 8. Market restraint analysis (current & future impact)
  • Fig. 9. SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10. Porter's five forces analysis
  • Fig. 11. Digital neuro biomarkers market, type outlook key takeaways (USD million)
  • Fig. 12. Digital neuro biomarkers market: type movement analysis (USD million), 2023 & 2030
  • Fig. 13. Wearable market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 14. Mobile based applications market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 15. Sensors market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 16. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 17. Digital neuro biomarkers market, clinical practice outlook key takeaways (USD million)
  • Fig. 18. Digital neuro biomarkers market: clinical practice movement analysis (USD million), 2023 & 2030
  • Fig. 19. Diagnostic psychiatric digital biomarkers market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 20. Monitoring psychiatric digital biomarkers market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 21. Predictive and prognostic psychiatric digital biomarkers market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 22. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 23. Digital neuro biomarkers market, end use outlook key takeaways (USD million)
  • Fig. 24. Digital neuro biomarkers market: end use movement analysis (USD million), 2023 & 2030
  • Fig. 25. Healthcare companies market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 26. Healthcare providers market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 27. Payers market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 28. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 29. Digital neuro biomarkers market: regional key takeaways (USD million)
  • Fig. 30. Digital neuro biomarkers market: regional outlook, 2023 & 2030, USD million
  • Fig. 31. North America Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 32. U.S. Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 33. Canada Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 34. Mexico Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 35. Europe Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 36. UK Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 37. Germany Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 38. France Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 39. Spain Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 40. Italy Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 41. Norway Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 42. Denmark Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 43. Sweden Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 44. Asia Pacific Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 45. China Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 46. Japan Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 47. India Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 48. South Korea Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 49. Australia Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 50. Thailand Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 51. Latin America Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 52. Brazil Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 53. Argentina Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 54. Middle East and Africa Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 55. South Africa Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 56. Saudi Arabia Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 57. UAE Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 58. Kuwait Digital neuro biomarkers market estimates and forecasts, 2018 - 2030 (USD million)
  • Fig. 59. List of key emerging company's/technology disruptors/innovators